The additive value of gated SPET myocardial perfusion imaging in patients with known and suspected coronary artery disease

Nuclear Medicine Communications

Volumn 22, Issue 1, 2001, Pages 45-55

  Bavelaar Croon, C D L ^a   Atsma, D E ^a   van der Wall, E E ^a   Dibbets Schneider, P ^a   Zwinderman, A H ^b   Pauwels, E K J ^b  

^a Divisions of Nuclear Medicine   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Coronary artery disease; Gated SPET imaging; Left ventricular function.; Myocardial infarction; Myocardial perfusion

Indexed keywords

TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; GATED IMAGING; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PERFUSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE DIAGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CORONARY CIRCULATION; CORONARY DISEASE; FEMALE; HEART; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL STUNNING; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PERFUSION; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR FUNCTION, LEFT;

EID: 0035119387     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200101000-00007     Document Type: Article

References (43)

1. Thorley PJ, Ball J, Sheard KL, Sivananthan UM. Evaluation of 99Tcm-tetrofosmin as a myocardial perfusion agent in routine clinical use. Nucl Med Commun 1995; 16: 733-740.
2. Acampa W, Cuocolo A, Sullo P et al. Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease. J Nucl Cardiol 1998; 5: 265-274.
3. DePuey EG, Nichols K, Dobrinsky C. Left ventricular ejection fraction assessed from gated technetium-99m-sestamibi SPECT. J Nucl Med 1993; 34: 1871-1876.
4. Marzullo P, Marcassa C, Sambuceti G, Parodi O, L'Abbatte A. The clinical usefulness of electrocardiogram-gated Tc-99m methoxy-isobutyl-isonitrile images in the detection of basal wall motion abnormalities and reversibility of stress induced perfusion defects. Int J Card Imaging 1992; 8: 131-141.
5. Mochizuki T, Murase K, Tanaka H, Kondoh T, Hamamoto K, Tauxe WN. Assessment of left ventricular volume using ECG-gated SPECT with technetium-99m-MIBI and technetium-99m-tetrofosmin. J Nucl Med 1997; 38: 53-57.
6. Nichols K, DePuey EG, Rozanski A, Salensky H, Friedman MI. Image enhancement of severely hypoperfused myocardia for computation of tomographic ejection fraction. J Nucl Med 1997; 38: 1411-1417.
7. Calnon DA, Kastner RJ, Smith WH, Segalla D, Beller GA, Watson DD. Validation of a new counts-based gated single photon emission computed tomography method for quantifying left ventricular systolic function: comparison with equilibrium radionuclide angiography. J Nucl Cardiol 1997; 4: 464-471.
8. Nichols K, DePuey EG, Krasnow N, Lefkowitz D, Rozanski A. Reliability of enhanced gated SPECT in assessing wall motion of severely hypoperfused myocardium: echocardiographic validation. J Nucl Cardiol 1998; 5: 387-394.
9. Germano G, Kiat H, Kavanagh PB et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995; 36: 2138-2147.
10. Germano G, Kavanagh PB, Berman DS. An automatic approach to the analysis, quantitation and review of perfusion and function from myocardial perfusion SPECT images. Int J Cardiac Imaging 1997; 13: 337-346.
11. Germano G, Erel J, Lewin H, Kavanagh PB, Berman DS. Automatic quantitation of regional myocardial wall motion and thickening from gated technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1997; 30: 1360-1367.
12. Germano G, Erel J, Kiat H, Kavanagh PB, Berman DS. Quantitative LVEF and qualitative regional function from gated thallium-201 perfusion SPECT. J Nucl Med 1997; 38: 749-754.
13. Iskandrian AE, Germano G, VanDecker W et al. Validation of left ventricular volume measurements by gated SPECT 99mTc-labeled sestamibi imaging. J Nucl Cardiol 1998; 5: 574-578.
14. DePuey EG, Rozanski A. Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact. J Nucl Med 1995; 36: 952-955.
15. Smanio PEP, Watson DD, Segalla DL, Vinson EL, Smith WH, Beller GA. Value of gating of technetium-99m sestamibi single-photon emission computed tomographic imaging. J Am Coll Cardiol Dec 1997; 30: 1687-1692.
16. Taillefer R, DePuey EG, Udelson JE, Beller GA, Latour Y, Reeves F. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 1997; 29: 69-77.
17. Choi JY, Lee KH, Kim SJ et al. Gating provides improved accuracy for differentiating artifacts from true lesions in equivocal fixed defects on technetium 99m tetrofosmin perfusion SPECT. J Nucl Cardiol 1998; 5: 395-401.
18. Berman DS, Germano G. Evaluation of ventricular ejection fraction, wall motion, wall thickening, and other parameters with gated myocardial perfusion single-photon emission computed tomography. J Nucl Cardiol 1997; 4: S169-S171.
19. Miles KA. How does gated SPET alter reporting of myocardial perfusion studies? Nucl Med Commun 1997; 18: 915-921.
20. Eck-Smit van BL, Poots S, Zwinderman AH, Bruschke AV, Pauwels EK, van der Wall EE. Myocardial SPECT imaging with 99Tcm-tetrofosmin in clinical practice: comparison of a 1 day and 2 day imaging protocol. Nucl Med Commun 1997; 18: 24-30.
21. Johnson LL, Verdesca SA, Aude WY et al. Postischemic stunning can affect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms. J Am Coll Cardiol 1997; 30: 1641-1648.
22. Snapper HJ, Shea NL, Konstam MA, Oates E, Udelson JE. Combined analysis of resting regional wall thickening and stress perfusion with electrocardiographic-gated technetium 99m-labeled sestamibi single-photon emission computed tomography: prediction of stress defect reversibility. J Nucl Cardiol 1997; 4: 3-10.
23. Chua T, Kiat H, Germano G et al. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability. Correlation with echocardiography and rest thallium-201 scintigraphy. J Am Coll Cardiol 1994; 23: 1107-1114.
24. Rocco TP, Dilsizian V, Strauss HW, Boucher CA. Technetium-99m isonitrile myocardial uptake at rest. II. Relation to clinical markers of potential viability. J Am Coll Cardiol 1989; 14: 1678-1684.
25. Bonow RO. Identification of viable myocardium. Circulation 1996; 94: 2674-2680.
26. Niemeyer MG, Kuijper AFM, Meeder JG, Cramer MJM, Cleophas AJM, van der Wall EE. Comparison of thallium scintigraphy and positron emission tomography. Angiology 1997; 48: 843-853.
27. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997; 30: 1451-1460.
28. Bax JJ, van Eck-Smit BLF, van der Wall EE. Assessment of tissue viability: clinical demand and problems. Eur Heart J 1998; 19: 847-858.
29. Nicolai E, Cuocolo A, Pace L et al. Assessment of systolic wall thickening using technetium-99m methoxyisobutylisonitrile in patients with coronary artery disease: relation to thallium-201 scintigraphy with re-injection. Eur J Nucl Med 1995; 22: 1017-1022.
30. Yamashita K, Tamaki N, Yonekura Y et al. Regional wall thickening of left ventricle evaluated by gated positron emission tomography in relation to myocardial perfusion and glucose metabolism. J Nucl Med 1991; 32: 679-685.
31. Levine MG, McGill CC, Ahlberg AW et al. Functional assessment with electrocardiographic gated single-photon emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization. Am J Cardiol 1999; 83: 1-5.
32. Kloner RA, Allen J, Cox TA, Zheng Y, Ruiz CE. Stunned left ventricular myocardium after exercise treadmill testing in coronary artery disease. Am J Cardiol 1991; 68: 329-334.
33. Bonow RO. Gated myocardial perfusion imaging for measuring left ventricular function. J Am Coll Cardiol 1997; 30: 1649-1650.
34. Ambrosio G, Betocchi S, Pace L et al. Prolonged impairment of regional contractile function after resolution of exercise-induced angina. Evidence of myocardial stunning in patients with coronary artery disease. Circulation 1996; 94: 2455-2464.
35. Chareonthaitawee P, Christian TF, Miller TD, Hodge DO, Gibbons RJ. Correlation of resting first-pass left ventricular ejection fraction and resting myocardial infarct size. Am J Cardiol 1998; 81: 1281-1285.
36. Morris KG, Palmeri ST, Califf RM et al. Value of radionuclide angiography for predicting specific cardiac events after acute myocardial infarction. Am J Cardiol 1985; 55: 318-324.
37. Miller TD, Christian TF, Taliercio CP, Zinsmeister AR, Gibbons RJ. Severe exercise-induced ischemia does not identify high risk patients with normal left ventricular function and one- or two-vessel coronary artery disease. J Am Coll Cardiol 1994; 23: 219-224.
38. Johnson SH, Bigelow C, Lee KL, Pryor DB, Jones RH. Prediction of death and myocardial infarction by radionuclide angiocardiography in patients with suspected coronary artery disease. Am J Cardiol 1991; 67: 919-926.
39. Shaw LJ, Heinle SK, Borges-Neto S, Kesler K, Coleman RE, Jones RH. Prognosis by measurements of left ventricular function during exercise. J Nucl Med 1998; 39: 140-146.
40. Sharir T, Germano G, Kavanagh PB et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 1999; 100: 1035-1042.
41. Anagnostopoulos C, Gunning MG, Pennell DJ, Laney R, Proukakis H, Underwood SR. Regional myocardial motion and thickening assessed at rest by ECG-gated 99mTc-MIBI emission tomography and by magnetic resonance imaging. Eur J Nucl Med 1996; 23: 909-916.
42. Stollfuss JC, Haas F, Matsunari I et al. Regional myocardial wall thickening and global ejection fraction in patients with low angiographic left ventricular ejection fraction assessed by visual and quantitative resting ECG-gated 99mTc-tetrofosmin single-photon emission tomography and magnetic resonance imaging. Eur J Nucl Med 1998; 25: 522-530.
43. Vaduganathan P, He ZX, Vick III GW, Mahmarian JJ, Verani MS. Evaluation of left ventricular wall motion, volumes, and ejection fraction by gated myocardial tomography with technetium 99mTc-labelled tetrofosmin: A comparison with cine magnetic resonance imaging. J Nucl Cardiol 1999; 6: 3-10.